Article
[The role of hydrogen sulfide in acute lung injury during endotoxic shock and its relationship with nitric oxide and carbon monoxide].
Department of Pathophysiology, Hebei Medical University, Shijiazhuang 050017, China.
Zhonghua yi xue za zhi
08/2008;
88(32):2240-5.
pp.2240-5
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Hydrogen sulphide: novel opportunity for drug discovery.
[show abstract] [hide abstract]
ABSTRACT: Hydrogen sulphide (H(2) S) is emerging as an important endogenous modulator, which exhibits the beneficial effects of nitric oxide (NO) on the cardiovascular (CV) system, without producing toxic metabolites. H(2) S is biosynthesized in mammalian tissues by cystathionine-β-synthase and cystathionine-γ-lyase. H(2) S exhibits the antioxidant properties of inorganic and organic sulphites, behaving as a scavenger of reactive oxygen species. There is also clear evidence that H(2) S triggers other important effects, mainly mediated by the activation of ATP-sensitive potassium channels (K(ATP) ). This mechanism accounts for the vasorelaxing and cardioprotective effects of H(2) S. Furthermore, H(2) S inhibits smooth muscle proliferation and platelet aggregation. In non-CV systems, H(2) S regulates the functions of the central nervous system, as well as respiratory, gastroenteric, and endocrine systems. Conversely, H(2) S deficiency contributes to the pathogenesis of hypertension. Likewise, impairment of H(2) S biosynthesis is involved in CV complications associated with diabetes mellitus. There is also evidence of a cross-talk between the H(2) S and the endothelial NO pathways. In particular, recent observations indicate a possible pathogenic link between deficiencies of H(2) S activity and the progress of endothelial dysfunction. These biological aspects of endogenous H(2) S have led several authors to look at this mediator as "the new NO" that has given attractive opportunities to develop innovative classes of drugs. In this review, the main biological actions of H(2) S are discussed. Moreover, some examples of H(2) S-donors are shown, as well as some hybrids, in which H(2) S-releasing moieties are added to well-known drugs, for improving their pharmacodynamic profile or reducing the potential for adverse effects, are reported.Medicinal Research Reviews 11/2012; 32(6):1093-130. · 10.70 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
4 equal groups
acute lung injury
adult male SD rats
blood plasma
eNOS activity decrease
exogenous H2S donor]
LPS + NaHS group
LPS + PPG group
LPS)-treated group
lung injury
lung MPO
lung tissue cystathionine-gamma-lyase
lung tissue inducible NOS
lung tissue injury
lung tissue malonyldialdehyde
lung tissues
mean artery pressure
nitric oxide synthase
plasma H2S
polypropylene glycol